Antimalarial Drug Development and New Targets

Author： Macreadie I.   Ginsburg H.   Sirawaraporn W.   Tilley L.  

Publisher： Elsevier

ISSN： 0169-4758

Source： Parasitology Today, Vol.16, Iss.10, 2000-10, pp. : 438-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can Mosquitoes Be Bitten? A New Hope for Anti-Malarial Drug Design

By Brinen L.S.   Stout T.J.  

Structure, Vol. 11, Iss. 11, 2003-11 ,pp. : 1309-1310

Elsevier

Access to resources Recommend Favorite

Genotoxic evaluation of the antimalarial drug, fansidar, in cultured human lymphocytes

By Abou-Eisha A.   Afifi M.  

Cell Biology and Toxicology, Vol. 20, Iss. 5, 2004-09 ,pp. : 303-311

Springer Publishing Company

Access to resources Recommend Favorite

Finding Antifungal Drug Targets with Functional Genomics

By  

Diagnostic Innovation, Vol. 12, Iss. 2-3, 2002-09 ,pp. : 21-28

Adis International

Access to resources Recommend Favorite

Seeking new targets for antiparasitic agents

By Wiesner J.   Sanderbrand S.   Altincicek B.   Beck E.   Jomaa H.  

Parasitology Today, Vol. 17, Iss. 1, 2001-01 ,pp. : 7-7

Elsevier

Access to resources Recommend Favorite

Determining subcellular localization of novel drug targets by transient transfection in COS cells

By Simon Iris   Wright Meredith   Flohr Tanya   Hevezi Peter   Caras Ingrid  

Cytotechnology, Vol. 35, Iss. 3, 2001-05 ,pp. : 189-196

Springer Publishing Company

Access to resources Recommend Favorite